Mitoquinone for Postmenopausal Brain Health

This trial aims to determine if the supplement MitoQ (also known as mitoquinone) can improve brain artery health in postmenopausal women. It tests whether MitoQ reduces certain harmful molecules in the arteries, potentially enhancing brain function. Participants will take either MitoQ or a placebo daily for three months and monitor any changes. Women aged 60 or older, who have gone through menopause and are not on hormone therapies, might be suitable candidates. As an unphased trial, this study offers participants the opportunity to contribute to important research on brain health and potentially gain new insights into postmenopausal health.

The trial does not specify if you need to stop taking your current medications, but you must not have used hormone therapies or antioxidant supplements like CoQ10 in the past 3 months.

Research shows that MitoQ, a special antioxidant targeting the mitochondria, is generally safe for people. Studies have found that high doses of MitoQ, between 100 to 160 mg, are safe. In this trial, participants will take a much lower dose of 20 mg per day, indicating a low risk of significant side effects.

MitoQ is also available as a dietary supplement with a recommended dose of 10 mg per day. Although limited information exists on its effectiveness, it is considered safe to use. MitoQ is recognized as Generally Regarded as Safe (GRAS), meaning scientific data has reviewed and deemed it safe.

Unlike standard treatments for postmenopausal brain health, which often focus on hormone replacement or cognitive therapies, MitoQ stands out with its unique active ingredient, mitoquinol mesylate. This compound specifically targets mitochondria, the energy powerhouses of cells, to reduce oxidative stress. Researchers are excited about MitoQ because it offers a novel approach to potentially improve brain health by enhancing cellular energy production, which could lead to better cognitive function in postmenopausal women.

Research has shown that MitoQ, a special antioxidant targeting the energy centers of cells, may benefit brain health. In animal studies, mice given MitoQ demonstrated better memory and reduced brain stress. Another study found that combining MitoQ with exercise reduced inflammation and increased antioxidants in the brain. This trial will evaluate the effects of MitoQ, administered at 20 mg per day, on brain health in postmenopausal women. Specifically, MitoQ might improve the function of brain arteries by reducing harmful stress caused by oxygen particles in this group. While these results are promising, more research in humans is needed to confirm these effects.¹⁴⁶⁷⁸